These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 37172536)
1. A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers. Xue X; Qu H; Bo R; Zhang D; Zhu Z; Xiang B; Li L; Ricci M; Pan CX; Lin TY; Li Y Biomaterials; 2023 Aug; 299():122145. PubMed ID: 37172536 [TBL] [Abstract][Full Text] [Related]
2. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy. Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551 [TBL] [Abstract][Full Text] [Related]
3. Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments. Qu H; Li L; Chen H; Tang M; Cheng W; Lin TY; Li L; Li B; Xue X J Control Release; 2023 Nov; 363():361-375. PubMed ID: 37751826 [TBL] [Abstract][Full Text] [Related]
4. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy. Yasothamani V; Vivek R J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846 [TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment. Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202 [TBL] [Abstract][Full Text] [Related]
6. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence. Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603 [TBL] [Abstract][Full Text] [Related]
7. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer. Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591 [TBL] [Abstract][Full Text] [Related]
8. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy. Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439 [TBL] [Abstract][Full Text] [Related]
9. Photoacoustic mediated multifunctional tumor antigen trapping nanoparticles inhibit the recurrence and metastasis of ovarian cancer by enhancing tumor immunogenicity. Zhong X; Li C; Zhao G; Li M; Chen S; Cao Y; Wang Q; Sun J; Zhu S; Chang S J Nanobiotechnology; 2022 Nov; 20(1):468. PubMed ID: 36329515 [TBL] [Abstract][Full Text] [Related]
10. Treating Immunologically Cold Tumors by Precise Cancer Photoimmunotherapy with an Extendable Nanoplatform. Yu W; Sun J; Liu F; Yu S; Hu J; Zhao Y; Wang X; Liu X ACS Appl Mater Interfaces; 2020 Sep; 12(36):40002-40012. PubMed ID: 32805869 [TBL] [Abstract][Full Text] [Related]
11. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy. Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006 [TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer. He H; Liu L; Liang R; Zhou H; Pan H; Zhang S; Cai L Acta Biomater; 2020 Mar; 104():188-197. PubMed ID: 31945508 [TBL] [Abstract][Full Text] [Related]
13. Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapy. Xu W; Pang C; Song C; Qian J; Feola S; Cerullo V; Fan L; Yu H; Lehto VP Acta Biomater; 2022 Oct; 152():473-483. PubMed ID: 36087872 [TBL] [Abstract][Full Text] [Related]
14. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy. Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723 [TBL] [Abstract][Full Text] [Related]
15. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment. Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377 [TBL] [Abstract][Full Text] [Related]
16. Task-Specific Design of Immune-Augmented Nanoplatform to Enable High-Efficiency Tumor Immunotherapy. Zhang J; Zhang D; Li Q; Jiang Y; Song A; Li Z; Luan Y ACS Appl Mater Interfaces; 2019 Nov; 11(46):42904-42916. PubMed ID: 31657540 [TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors. Lorkowski ME; Atukorale PU; Bielecki PA; Tong KH; Covarrubias G; Zhang Y; Loutrianakis G; Moon TJ; Santulli AR; Becicka WM; Karathanasis E J Control Release; 2021 Feb; 330():1095-1105. PubMed ID: 33188827 [TBL] [Abstract][Full Text] [Related]
18. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy. Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594 [TBL] [Abstract][Full Text] [Related]
19. Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy. Yue J; Mei Q; Wang P; Miao P; Dong WF; Li L J Nanobiotechnology; 2022 Apr; 20(1):181. PubMed ID: 35392911 [TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]